Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 8/20 | 0.84 |
| ▸ | HIF1A | Q16665 | 8/20 | 0.72 |
| ▸ | PGR | P06401 | 6/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.72 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.72 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.72 |
| ▸ | AR | P10275 | 2/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.72 |
| ▸ | TNF | P01375 | 1/20 | 0.72 |
| ▸ | IL6 | P05231 | 1/20 | 0.72 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.72 |
| ▸ | GLUL | P15104 | 1/20 | 0.72 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.72 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.65 |
| ▸ | CNR1 | P21554 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL647326 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL3775851 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL4726540 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL12313064 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL23832187 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL647327 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL25129199 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL24861840 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL24622464 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 | |
| SCHEMBL21293123 | 1.00 | NR3C1 (0.84) | NR3C1HIF1APGRHSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4116314-A1 | METHOD FOR PREPARING 16ALPHA-HYDROXYPREDNISOLONE | Zhejiang Shenzhou Pharmaceutical Company Limited (CN) | 2023-01-11 | — | — | EP | disclosed |
| US-8158780-B2 | Processes for the preparation of ciclesonide and its crystal modification | CIPLA LIMITED (IN) | 2012-04-17 | — | — | US | disclosed |
| US-8158780-B2 | Processes for the preparation of ciclesonide and its crystal modification | CIPLA LIMITED (IN) | 2012-04-17 | — | — | US | disclosed |
| US-20100222572-A1 | PROCESSES FOR THE PREPARATION OF CICLESONIDE AND ITS CRYSTAL MODIFICATION | CIPLA LIMITED (IN) | 2010-09-02 | — | — | US | disclosed |
| US-20100222572-A1 | PROCESSES FOR THE PREPARATION OF CICLESONIDE AND ITS CRYSTAL MODIFICATION | CIPLA LIMITED (IN) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222572-A1 | PROCESSES FOR THE PREPARATION OF CICLESONIDE AND ITS CRYSTAL MODIFICATION | CYP17A1, CYP4A11, NR5A1 | NR3C1 17/4885HIF1A 2734/4885PGR 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.